Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.China |
First Approval Date23 Feb 2020 |
100 Clinical Results associated with Guangdong Taikang Pharmaceutical Co., Ltd.
0 Patents (Medical) associated with Guangdong Taikang Pharmaceutical Co., Ltd.
100 Deals associated with Guangdong Taikang Pharmaceutical Co., Ltd.
100 Translational Medicine associated with Guangdong Taikang Pharmaceutical Co., Ltd.